The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Plasmid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Plasmid in Transfection is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Plasmid include Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics and Copernicus Therapeutics Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plasmid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid.
Report Scope
The Plasmid market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasmid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aldevron
GenScript
PlasmidFactory GmbH & Co. KG
VGXI Inc.
Oxford Genetics Ltd.
Applied StemCell
Altogen Biosystems
Cobra Biologics
Copernicus Therapeutics Inc.
Takara Bio
InvivoGen
Miltenyi Biotec
Medigene Sdn Bhd
MaxCyte Inc.
Mirus Bio LLC
MolMed S.p.A.
GenePharma
Polyplus Transfection
Segment by Type
F-Plasmids
Col Plasmids
Resistance Plasmids
Cryptic Plasmids
Degradative Plasmids
Virulence Plasmids
Segment by Application
Transfection
Recombinant DNA Technology
Gene Therapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Plasmid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Plasmid in Transfection is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Plasmid include Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics and Copernicus Therapeutics Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plasmid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid.
Report Scope
The Plasmid market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasmid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aldevron
GenScript
PlasmidFactory GmbH & Co. KG
VGXI Inc.
Oxford Genetics Ltd.
Applied StemCell
Altogen Biosystems
Cobra Biologics
Copernicus Therapeutics Inc.
Takara Bio
InvivoGen
Miltenyi Biotec
Medigene Sdn Bhd
MaxCyte Inc.
Mirus Bio LLC
MolMed S.p.A.
GenePharma
Polyplus Transfection
Segment by Type
F-Plasmids
Col Plasmids
Resistance Plasmids
Cryptic Plasmids
Degradative Plasmids
Virulence Plasmids
Segment by Application
Transfection
Recombinant DNA Technology
Gene Therapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 F-Plasmids
1.2.3 Col Plasmids
1.2.4 Resistance Plasmids
1.2.5 Cryptic Plasmids
1.2.6 Degradative Plasmids
1.2.7 Virulence Plasmids
1.3 Market by Application
1.3.1 Global Plasmid Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Transfection
1.3.3 Recombinant DNA Technology
1.3.4 Gene Therapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid Market Perspective (2019-2030)
2.2 Plasmid Growth Trends by Region
2.2.1 Global Plasmid Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Plasmid Historic Market Size by Region (2019-2024)
2.2.3 Plasmid Forecasted Market Size by Region (2025-2030)
2.3 Plasmid Market Dynamics
2.3.1 Plasmid Industry Trends
2.3.2 Plasmid Market Drivers
2.3.3 Plasmid Market Challenges
2.3.4 Plasmid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid Players by Revenue
3.1.1 Global Top Plasmid Players by Revenue (2019-2024)
3.1.2 Global Plasmid Revenue Market Share by Players (2019-2024)
3.2 Global Plasmid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid Revenue
3.4 Global Plasmid Market Concentration Ratio
3.4.1 Global Plasmid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid Revenue in 2023
3.5 Plasmid Key Players Head office and Area Served
3.6 Key Players Plasmid Product Solution and Service
3.7 Date of Enter into Plasmid Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid Breakdown Data by Type
4.1 Global Plasmid Historic Market Size by Type (2019-2024)
4.2 Global Plasmid Forecasted Market Size by Type (2025-2030)
5 Plasmid Breakdown Data by Application
5.1 Global Plasmid Historic Market Size by Application (2019-2024)
5.2 Global Plasmid Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Plasmid Market Size (2019-2030)
6.2 North America Plasmid Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Plasmid Market Size by Country (2019-2024)
6.4 North America Plasmid Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid Market Size (2019-2030)
7.2 Europe Plasmid Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Plasmid Market Size by Country (2019-2024)
7.4 Europe Plasmid Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid Market Size (2019-2030)
8.2 Asia-Pacific Plasmid Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Plasmid Market Size by Region (2019-2024)
8.4 Asia-Pacific Plasmid Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid Market Size (2019-2030)
9.2 Latin America Plasmid Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Plasmid Market Size by Country (2019-2024)
9.4 Latin America Plasmid Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid Market Size (2019-2030)
10.2 Middle East & Africa Plasmid Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Plasmid Market Size by Country (2019-2024)
10.4 Middle East & Africa Plasmid Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aldevron
11.1.1 Aldevron Company Detail
11.1.2 Aldevron Business Overview
11.1.3 Aldevron Plasmid Introduction
11.1.4 Aldevron Revenue in Plasmid Business (2019-2024)
11.1.5 Aldevron Recent Development
11.2 GenScript
11.2.1 GenScript Company Detail
11.2.2 GenScript Business Overview
11.2.3 GenScript Plasmid Introduction
11.2.4 GenScript Revenue in Plasmid Business (2019-2024)
11.2.5 GenScript Recent Development
11.3 PlasmidFactory GmbH & Co. KG
11.3.1 PlasmidFactory GmbH & Co. KG Company Detail
11.3.2 PlasmidFactory GmbH & Co. KG Business Overview
11.3.3 PlasmidFactory GmbH & Co. KG Plasmid Introduction
11.3.4 PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2019-2024)
11.3.5 PlasmidFactory GmbH & Co. KG Recent Development
11.4 VGXI Inc.
11.4.1 VGXI Inc. Company Detail
11.4.2 VGXI Inc. Business Overview
11.4.3 VGXI Inc. Plasmid Introduction
11.4.4 VGXI Inc. Revenue in Plasmid Business (2019-2024)
11.4.5 VGXI Inc. Recent Development
11.5 Oxford Genetics Ltd.
11.5.1 Oxford Genetics Ltd. Company Detail
11.5.2 Oxford Genetics Ltd. Business Overview
11.5.3 Oxford Genetics Ltd. Plasmid Introduction
11.5.4 Oxford Genetics Ltd. Revenue in Plasmid Business (2019-2024)
11.5.5 Oxford Genetics Ltd. Recent Development
11.6 Applied StemCell
11.6.1 Applied StemCell Company Detail
11.6.2 Applied StemCell Business Overview
11.6.3 Applied StemCell Plasmid Introduction
11.6.4 Applied StemCell Revenue in Plasmid Business (2019-2024)
11.6.5 Applied StemCell Recent Development
11.7 Altogen Biosystems
11.7.1 Altogen Biosystems Company Detail
11.7.2 Altogen Biosystems Business Overview
11.7.3 Altogen Biosystems Plasmid Introduction
11.7.4 Altogen Biosystems Revenue in Plasmid Business (2019-2024)
11.7.5 Altogen Biosystems Recent Development
11.8 Cobra Biologics
11.8.1 Cobra Biologics Company Detail
11.8.2 Cobra Biologics Business Overview
11.8.3 Cobra Biologics Plasmid Introduction
11.8.4 Cobra Biologics Revenue in Plasmid Business (2019-2024)
11.8.5 Cobra Biologics Recent Development
11.9 Copernicus Therapeutics Inc.
11.9.1 Copernicus Therapeutics Inc. Company Detail
11.9.2 Copernicus Therapeutics Inc. Business Overview
11.9.3 Copernicus Therapeutics Inc. Plasmid Introduction
11.9.4 Copernicus Therapeutics Inc. Revenue in Plasmid Business (2019-2024)
11.9.5 Copernicus Therapeutics Inc. Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Detail
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Plasmid Introduction
11.10.4 Takara Bio Revenue in Plasmid Business (2019-2024)
11.10.5 Takara Bio Recent Development
11.11 InvivoGen
11.11.1 InvivoGen Company Detail
11.11.2 InvivoGen Business Overview
11.11.3 InvivoGen Plasmid Introduction
11.11.4 InvivoGen Revenue in Plasmid Business (2019-2024)
11.11.5 InvivoGen Recent Development
11.12 Miltenyi Biotec
11.12.1 Miltenyi Biotec Company Detail
11.12.2 Miltenyi Biotec Business Overview
11.12.3 Miltenyi Biotec Plasmid Introduction
11.12.4 Miltenyi Biotec Revenue in Plasmid Business (2019-2024)
11.12.5 Miltenyi Biotec Recent Development
11.13 Medigene Sdn Bhd
11.13.1 Medigene Sdn Bhd Company Detail
11.13.2 Medigene Sdn Bhd Business Overview
11.13.3 Medigene Sdn Bhd Plasmid Introduction
11.13.4 Medigene Sdn Bhd Revenue in Plasmid Business (2019-2024)
11.13.5 Medigene Sdn Bhd Recent Development
11.14 MaxCyte Inc.
11.14.1 MaxCyte Inc. Company Detail
11.14.2 MaxCyte Inc. Business Overview
11.14.3 MaxCyte Inc. Plasmid Introduction
11.14.4 MaxCyte Inc. Revenue in Plasmid Business (2019-2024)
11.14.5 MaxCyte Inc. Recent Development
11.15 Mirus Bio LLC
11.15.1 Mirus Bio LLC Company Detail
11.15.2 Mirus Bio LLC Business Overview
11.15.3 Mirus Bio LLC Plasmid Introduction
11.15.4 Mirus Bio LLC Revenue in Plasmid Business (2019-2024)
11.15.5 Mirus Bio LLC Recent Development
11.16 MolMed S.p.A.
11.16.1 MolMed S.p.A. Company Detail
11.16.2 MolMed S.p.A. Business Overview
11.16.3 MolMed S.p.A. Plasmid Introduction
11.16.4 MolMed S.p.A. Revenue in Plasmid Business (2019-2024)
11.16.5 MolMed S.p.A. Recent Development
11.17 GenePharma
11.17.1 GenePharma Company Detail
11.17.2 GenePharma Business Overview
11.17.3 GenePharma Plasmid Introduction
11.17.4 GenePharma Revenue in Plasmid Business (2019-2024)
11.17.5 GenePharma Recent Development
11.18 Polyplus Transfection
11.18.1 Polyplus Transfection Company Detail
11.18.2 Polyplus Transfection Business Overview
11.18.3 Polyplus Transfection Plasmid Introduction
11.18.4 Polyplus Transfection Revenue in Plasmid Business (2019-2024)
11.18.5 Polyplus Transfection Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Plasmid Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of F-Plasmids
Table 3. Key Players of Col Plasmids
Table 4. Key Players of Resistance Plasmids
Table 5. Key Players of Cryptic Plasmids
Table 6. Key Players of Degradative Plasmids
Table 7. Key Players of Virulence Plasmids
Table 8. Global Plasmid Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Plasmid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Plasmid Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Plasmid Market Share by Region (2019-2024)
Table 12. Global Plasmid Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Plasmid Market Share by Region (2025-2030)
Table 14. Plasmid Market Trends
Table 15. Plasmid Market Drivers
Table 16. Plasmid Market Challenges
Table 17. Plasmid Market Restraints
Table 18. Global Plasmid Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Plasmid Market Share by Players (2019-2024)
Table 20. Global Top Plasmid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid as of 2023)
Table 21. Ranking of Global Top Plasmid Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Plasmid Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Plasmid Product Solution and Service
Table 25. Date of Enter into Plasmid Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Plasmid Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Plasmid Revenue Market Share by Type (2019-2024)
Table 29. Global Plasmid Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Plasmid Revenue Market Share by Type (2025-2030)
Table 31. Global Plasmid Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Plasmid Revenue Market Share by Application (2019-2024)
Table 33. Global Plasmid Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Plasmid Revenue Market Share by Application (2025-2030)
Table 35. North America Plasmid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Plasmid Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Plasmid Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Plasmid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Plasmid Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Plasmid Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Plasmid Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Plasmid Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Plasmid Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Plasmid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Plasmid Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Plasmid Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Plasmid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Plasmid Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Plasmid Market Size by Country (2025-2030) & (US$ Million)
Table 50. Aldevron Company Detail
Table 51. Aldevron Business Overview
Table 52. Aldevron Plasmid Product
Table 53. Aldevron Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 54. Aldevron Recent Development
Table 55. GenScript Company Detail
Table 56. GenScript Business Overview
Table 57. GenScript Plasmid Product
Table 58. GenScript Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 59. GenScript Recent Development
Table 60. PlasmidFactory GmbH & Co. KG Company Detail
Table 61. PlasmidFactory GmbH & Co. KG Business Overview
Table 62. PlasmidFactory GmbH & Co. KG Plasmid Product
Table 63. PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 64. PlasmidFactory GmbH & Co. KG Recent Development
Table 65. VGXI Inc. Company Detail
Table 66. VGXI Inc. Business Overview
Table 67. VGXI Inc. Plasmid Product
Table 68. VGXI Inc. Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 69. VGXI Inc. Recent Development
Table 70. Oxford Genetics Ltd. Company Detail
Table 71. Oxford Genetics Ltd. Business Overview
Table 72. Oxford Genetics Ltd. Plasmid Product
Table 73. Oxford Genetics Ltd. Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 74. Oxford Genetics Ltd. Recent Development
Table 75. Applied StemCell Company Detail
Table 76. Applied StemCell Business Overview
Table 77. Applied StemCell Plasmid Product
Table 78. Applied StemCell Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 79. Applied StemCell Recent Development
Table 80. Altogen Biosystems Company Detail
Table 81. Altogen Biosystems Business Overview
Table 82. Altogen Biosystems Plasmid Product
Table 83. Altogen Biosystems Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 84. Altogen Biosystems Recent Development
Table 85. Cobra Biologics Company Detail
Table 86. Cobra Biologics Business Overview
Table 87. Cobra Biologics Plasmid Product
Table 88. Cobra Biologics Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 89. Cobra Biologics Recent Development
Table 90. Copernicus Therapeutics Inc. Company Detail
Table 91. Copernicus Therapeutics Inc. Business Overview
Table 92. Copernicus Therapeutics Inc. Plasmid Product
Table 93. Copernicus Therapeutics Inc. Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 94. Copernicus Therapeutics Inc. Recent Development
Table 95. Takara Bio Company Detail
Table 96. Takara Bio Business Overview
Table 97. Takara Bio Plasmid Product
Table 98. Takara Bio Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 99. Takara Bio Recent Development
Table 100. InvivoGen Company Detail
Table 101. InvivoGen Business Overview
Table 102. InvivoGen Plasmid Product
Table 103. InvivoGen Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 104. InvivoGen Recent Development
Table 105. Miltenyi Biotec Company Detail
Table 106. Miltenyi Biotec Business Overview
Table 107. Miltenyi Biotec Plasmid Product
Table 108. Miltenyi Biotec Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 109. Miltenyi Biotec Recent Development
Table 110. Medigene Sdn Bhd Company Detail
Table 111. Medigene Sdn Bhd Business Overview
Table 112. Medigene Sdn Bhd Plasmid Product
Table 113. Medigene Sdn Bhd Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 114. Medigene Sdn Bhd Recent Development
Table 115. MaxCyte Inc. Company Detail
Table 116. MaxCyte Inc. Business Overview
Table 117. MaxCyte Inc. Plasmid Product
Table 118. MaxCyte Inc. Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 119. MaxCyte Inc. Recent Development
Table 120. Mirus Bio LLC Company Detail
Table 121. Mirus Bio LLC Business Overview
Table 122. Mirus Bio LLC Plasmid Product
Table 123. Mirus Bio LLC Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 124. Mirus Bio LLC Recent Development
Table 125. MolMed S.p.A. Company Detail
Table 126. MolMed S.p.A. Business Overview
Table 127. MolMed S.p.A. Plasmid Product
Table 128. MolMed S.p.A. Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 129. MolMed S.p.A. Recent Development
Table 130. GenePharma Company Detail
Table 131. GenePharma Business Overview
Table 132. GenePharma Plasmid Product
Table 133. GenePharma Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 134. GenePharma Recent Development
Table 135. Polyplus Transfection Company Detail
Table 136. Polyplus Transfection Business Overview
Table 137. Polyplus Transfection Plasmid Product
Table 138. Polyplus Transfection Revenue in Plasmid Business (2019-2024) & (US$ Million)
Table 139. Polyplus Transfection Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasmid Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Plasmid Market Share by Type: 2023 VS 2030
Figure 3. F-Plasmids Features
Figure 4. Col Plasmids Features
Figure 5. Resistance Plasmids Features
Figure 6. Cryptic Plasmids Features
Figure 7. Degradative Plasmids Features
Figure 8. Virulence Plasmids Features
Figure 9. Global Plasmid Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Plasmid Market Share by Application: 2023 VS 2030
Figure 11. Transfection Case Studies
Figure 12. Recombinant DNA Technology Case Studies
Figure 13. Gene Therapy Case Studies
Figure 14. Others Case Studies
Figure 15. Plasmid Report Years Considered
Figure 16. Global Plasmid Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Plasmid Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Plasmid Market Share by Region: 2023 VS 2030
Figure 19. Global Plasmid Market Share by Players in 2023
Figure 20. Global Top Plasmid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Plasmid Revenue in 2023
Figure 22. North America Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Plasmid Market Share by Country (2019-2030)
Figure 24. United States Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Plasmid Market Share by Country (2019-2030)
Figure 28. Germany Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Plasmid Market Share by Region (2019-2030)
Figure 36. China Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Plasmid Market Share by Country (2019-2030)
Figure 44. Mexico Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Plasmid Market Share by Country (2019-2030)
Figure 48. Turkey Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Aldevron Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 51. GenScript Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 52. PlasmidFactory GmbH & Co. KG Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 53. VGXI Inc. Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 54. Oxford Genetics Ltd. Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 55. Applied StemCell Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 56. Altogen Biosystems Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 57. Cobra Biologics Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 58. Copernicus Therapeutics Inc. Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 59. Takara Bio Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 60. InvivoGen Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 61. Miltenyi Biotec Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 62. Medigene Sdn Bhd Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 63. MaxCyte Inc. Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 64. Mirus Bio LLC Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 65. MolMed S.p.A. Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 66. GenePharma Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 67. Polyplus Transfection Revenue Growth Rate in Plasmid Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
